Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Thrombocytopenia (CIT)”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Very early researchLooking for participantsNCT07048249
What this trial is testing

Single Arm Romiplostim to Prevent CIT

Who this might be right for
Ewings SarcomaChemotherapy Induced Thrombocytopenia
Children's Hospital Medical Center, Cincinnati 26
Early research (Phase 1)Active Not RecruitingNCT05426369
What this trial is testing

A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)

Who this might be right for
Chemotherapy-induced Thrombocytopenia (CIT)
Sichuan Clover Biopharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00413283
What this trial is testing

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerChemotherapy-Induced ThrombocytopeniaNon-Small Cell Lung Cancer+5 more
Amgen 63
Large-scale testing (Phase 3)Study completedNCT03471078
What this trial is testing

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Sobi, Inc. 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT05772546
What this trial is testing

Avatrombopag vs. Placebo for CIT in GI Malignancies

Who this might be right for
Gastrointestinal CancerGastrointestinal NeoplasmsChemotherapy-Induced Thrombocytopenia
Hanny Al-Samkari, MD 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05944211
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
RenJi Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00283439
What this trial is testing

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Who this might be right for
Chemotherapy-Induced ThrombocytopeniaHodgkin's LymphomaNon-Hodgkin's Lymphoma+3 more
Amgen 39
Early research (Phase 1)Ended earlyNCT01491594
What this trial is testing

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Who this might be right for
Sarcoma, Soft TissueOsteosarcomaNeoplasms, Connective and Soft Tissue
Duke University 1
Post-approval studies (Phase 4)UnknownNCT03633019
What this trial is testing

High-dose Use of rhTPO in CIT Patients

Who this might be right for
Thrombocytopenia
First Affiliated Hospital Xi'an Jiaotong University 50
Not applicableStudy completedNCT02650700
What this trial is testing

Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC (SPLEENIR)

Who this might be right for
Chemotherapy in Non-Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 100